Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours-Reference-Cited by-同舟云学术

Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours

Published:2012-11-06 Issue:11 Volume:7 Page:e47595
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bradtmöller Maren,Hartmann Christian,Zietsch Jan,Jäschke Sebastian,Mautner Victor-F,Kurtz Andreas,Park Su-Jin,Baier Michael,Harder Anja,Reuss David,von Deimling Andreas,Heppner Frank L.,Holtkamp Nikola

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Huson SM (1994) Neurofibromatosis 1: a clinical and genetic overview. In: Huson SM, Hughes RAC, editors. The Neurofibromatoses. London: Chapman and Hall Medical. 160–203.

2. Malignant peripheral nerve sheath tumours in neurofibromatosis 1;DG Evans;J Med Genet,2002

3. TP53 mutations are frequent in malignant NF1 tumors;E Legius;Genes Chromosomes Cancer,1994

4. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas;HP Kourea;Am J Pathol,1999

5. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms;A Perry;J Neuropathol Exp Neurol,2002

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Giant Malignant Peripheral Nerve Sheath Tumor of Neck;Korean Society of Head and Neck Oncology;2024-05-30

2. p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs;Oncogene;2024-03-13

3. Resección multivisceral para el tratamiento de un tumor maligno de la vaina del nervio periférico intraabdominal;Revista Colombiana de Cirugía;2024-02-19

4. Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets;Expert Opinion on Therapeutic Targets;2024-01-26

5. Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency;Cancers;2023-12-12